Viatris (VTRS) Shares Outstanding (Weighted Average) (2018 - 2021)
Viatris (VTRS) recorded quarterly Shares Outstanding (Weighted Average) of $1.2 billion in Q2 2021, little changed quarter-over-quarter from $1.2 billion in Q1 2021, and up 1208799900.0% on a YoY basis from N/an in Q2 2020.
Viatris (VTRS) Shares Outstanding (Weighted Average) (2018 - 2021) Analysis & Trends
Viatris' Shares Outstanding (Weighted Average) history runs 4 years deep, the most recent figure standing at $1.2 billion for Q2 2021.
- In Q2 2021, Shares Outstanding (Weighted Average) rose 1208799900.0% year-over-year to $1.2 billion; the TTM figure through Jun 2021 stood at $1.2 billion (up 1208799900.0% YoY), while the FY2019 annual figure was $515.7 million, changed 0.23% from the prior year.
- Shares Outstanding (Weighted Average) was $1.2 billion for Q2 2021 at Viatris, roughly flat from $1.2 billion in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.2 billion in Q2 2021 to a low of $100.0 in Q2 2020.
- Historically, Shares Outstanding (Weighted Average) has averaged $664.7 million across 4 years, with a median of $515.7 million in 2019.
- Biggest YoY gain for Shares Outstanding (Weighted Average) was 1208799900.0% in 2021; the steepest drop was 0.1% in 2021.
- A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $514.5 million in 2018, then climbed by 0.23% to $515.7 million in 2019, then plunged by 100.0% to $100.0 in 2020, then surged by 1208799900.0% to $1.2 billion in 2021.
- The last three Shares Outstanding (Weighted Average) figures came in at $1.2 billion (Q2 2021), $1.2 billion (Q1 2021), and $100.0 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Viatris | - | - | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 1.21 Bn |
| Mar 31, 2021 | 1.21 Bn |
| Sep 27, 2020 | 100.00 |
| Jun 28, 2020 | 100.00 |
| Mar 31, 2020 | 1.21 Bn |
| Dec 31, 2019 | 515.70 Mn |
| Dec 31, 2018 | 514.50 Mn |